1,432
Views
37
CrossRef citations to date
0
Altmetric
Original Articles

Standardization of Nomenclature for Ocular Tuberculosis – Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

, MD, FRCSORCID Icon, , MDORCID Icon, , PhD, , MMed, , MD, , MBBS, , PhD, , MS, , MD, , FRCOphthORCID Icon, , MD, , MDORCID Icon, , MD, , MD, , DNB, , MD, , MD, , MD, , MDORCID Icon, , MD, , FRCOphth, , PhD, , MD, , PhD, , MD, , MDORCID Icon, , MDORCID Icon, , MD, , MD, , DNB, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , PhD, , MD, , MDORCID Icon, ORCID Icon, , PhD, , PhD, , PhD, , PhD, , PhDORCID Icon, , PhD, , MD, , DNB, , MS, , MDORCID Icon, , DNB, , DNB, , PhD, , MS, , PhD, , MD, , MD, , PhD, , FRCOphth, , MD, , MD, , MD, , MD, , PhD, , DNB, , PhD, , MD, , MD, , MD, , PhD, , PhD, , FRCS, , PhDORCID Icon, , MSORCID Icon, , MS, , MS, , MD, , FRCS, , MD, , FRCS, , DNB, , PhD, , PhD, , MD, , MD, , MD, , PhD, , PhD, , FRCOphth, , MS & show all
Pages 74-84 | Received 03 Aug 2019, Accepted 06 Aug 2019, Published online: 10 Dec 2019
 
1

ABSTRACT

Purpose: To standardize a nomenclature system for defining clinical phenotypes, and outcome measures for reporting clinical and research data in patients with ocular tuberculosis (OTB).

Methods: Uveitis experts initially administered and further deliberated the survey in an open meeting to determine and propose the preferred nomenclature for terms related to the OTB, terms describing the clinical phenotypes and treatment and reporting outcomes.

Results: The group of experts reached a consensus on terming uveitis attributable to tuberculosis (TB) as tubercular uveitis. The working group introduced a SUN-compatible nomenclature that also defines disease “remission” and “cure”, both of which are relevant for reporting treatment outcomes.

Conclusion: A consensus nomenclature system has been adopted by a large group of international uveitis experts for OTB. The working group recommends the use of standardized nomenclature to prevent ambiguity in communication and to achieve the goal of spreading awareness of this blinding uveitis entity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.